第一单位：
School of Global Health, and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, and HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
作者：
Sivaporn,Gatechompol [1]
;
Wonngarm,Kittanamongkolchai [2]
;
Chutitorn,Ketloy [3]
;
Eakchai,Prompetchara [3]
;
Arunee,Thitithanyanont [4]
;
Anan,Jongkaewwattana [5]
;
Supranee,Buranapraditkun [3]
;
Mohamad-Gabriel,Alameh [6]
;
Sasiwimol,Ubolyam [7]
;
Jiratchaya,Sophonphan [8]
;
Tanakorn,Apornpong [8]
;
Stephen,Kerr [9]
;
Adeeba,Kamarulzaman [10]
;
Sarawut,Siwamogsatham [2]
;
Eugène,Kroon [11]
;
Thanyawee,Puthanakit [12]
;
Kanitha,Patarakul [13]
;
Tanapat,Palaga [14]
;
Wassana,Wijagkanalan [15]
;
Alexis,Carpenter [16]
;
Lina,Hong [16]
;
Drew,Weissman [6]
;
Kiat,Ruxrungtham [17]
;
ChulaVAC-001 study team
作者单位：
School of Global Health, and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, and HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
[1]
Clinical Research Center (Chula CRC), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
[2]
Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center-Chula VRC), and Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
[3]
Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
[4]
Virology and Cell Technology Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Bangkok, Thailand.
[5]
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
[6]
Clinical Research Laboratory/HIV-NAT Laboratory, Chula CRC, Faculty of Medicine; and HIVNAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
[7]
Biostatistics Unit, HIVNAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
[8]
Biostatistics Excellence Centre, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.;The Kirby Institute, University of New South Wales, Sydney, Australia.
[9]
Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
[10]
Institute of HIV Research and Innovation (IHRI), Bangkok, Thailand.
[11]
Department of Pediatrics, and Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
[12]
Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center-Chula VRC) and Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
[13]
Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center -Chula VRC), Faculty of Medicine; and Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
[14]
BioNet-Asia, Co. Ltd., Bangkok, Thailand.
[15]
GENEVANT SCIENCES CORPORATION, Vancouver, British Columbia, Canada.
[16]
Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center -Chula VRC), and School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. kiat.r@chula.ac.th.
[17]
DOI
10.1038/s41564-022-01271-0
PMID
36376393
发布时间
2023-12-13
换一批
